Mergers and acquisitions dominated the pharmaceutical and biopharmaceutical outsourced services industry in 2017. Additionally, 2017 saw numerous pharma/biopharma acquisitions to expand drug portfolios as well as to gain advanced drug development technologies. Leading global providers as well as smaller, specialty service providers were the target of acquisition efforts to gain/dominate market share. In line with increased outsourcing within the pharma/biopharma industry, demand for advanced tec...